Esmya (ulipristal acetate): suspension of the licence due to risk of serious liver injury

2020-03-18T14:25:49+00:00

Contact patients currently taking Esmya for uterine fibroids as soon as possible and advise them to stop their treatment. The licence for Esmya has been suspended to protect public health while a safety review is conducted f…